PIK3R1 Protein (p85α - Phosphoinositide-3-Kinase Regulatory Subunit 1)
Introduction PIK3R1 (Phosphoinositide-3-Kinase Regulatory Subunit 1), commonly known as p85α, is the major regulatory subunit of class IA phosphoinositide 3-kinases (PI3Ks). This critical signaling protein plays essential roles in cellular growth, survival, metabolism, and synaptic function. Dysregulation of p85α and PI3K/Akt signaling is strongly implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and stroke. This page provides comprehensive information about p85α structure, function, and its involvement in neurodegeneration.
<div class="infobox .infobox-protein">Protein Name | Phosphoinositide-3-Kinase Regulatory Subunit 1 (p85α) |Gene Symbol | [PIK3R1](/genes/pik3r1) |UniProt ID | [P27986](https://www.uniprot.org/uniprot/P27986) |Molecular Weight | 85 kDa |Amino Acids | 724 |Subcellular Localization | Cytoplasm, plasma membrane, endosomes |Protein Family | PI3K regulatory subunit (p85) family |Brain Expression | [Cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Cerebellum, Basal ganglia |PDB Structure | [4A0B](https://www.ebi.ac.uk/pdbe/entry/pdb/4A0B), [4JPS](https://www.ebi.ac.uk/pdbe/entry/pdb/4JPS), [4OVU](https://www.ebi.ac.uk/pdbe/entry/pdb/4OVU) |
Overview ...
PIK3R1 Protein (p85α - Phosphoinositide-3-Kinase Regulatory Subunit 1)
Introduction PIK3R1 (Phosphoinositide-3-Kinase Regulatory Subunit 1), commonly known as p85α, is the major regulatory subunit of class IA phosphoinositide 3-kinases (PI3Ks). This critical signaling protein plays essential roles in cellular growth, survival, metabolism, and synaptic function. Dysregulation of p85α and PI3K/Akt signaling is strongly implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and stroke. This page provides comprehensive information about p85α structure, function, and its involvement in neurodegeneration.
<div class="infobox .infobox-protein">Protein Name | Phosphoinositide-3-Kinase Regulatory Subunit 1 (p85α) |Gene Symbol | [PIK3R1](/genes/pik3r1) |UniProt ID | [P27986](https://www.uniprot.org/uniprot/P27986) |Molecular Weight | 85 kDa |Amino Acids | 724 |Subcellular Localization | Cytoplasm, plasma membrane, endosomes |Protein Family | PI3K regulatory subunit (p85) family |Brain Expression | [Cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Cerebellum, Basal ganglia |PDB Structure | [4A0B](https://www.ebi.ac.uk/pdbe/entry/pdb/4A0B), [4JPS](https://www.ebi.ac.uk/pdbe/entry/pdb/4JPS), [4OVU](https://www.ebi.ac.uk/pdbe/entry/pdb/4OVU) |
Overview p85α is encoded by the PIK3R1 gene and serves as the principal regulatory subunit of class IA PI3Ks. The protein regulates the catalytic p110 subunit (p110α, p110β, p110δ) by controlling its localization, stability, and enzymatic activity. p85α contains multiple protein-protein interaction domains that allow it to couple activated cell surface receptors to intracellular signaling cascades[@yu1998].
Protein Structure
Domain Architecture p85α (724 amino acids) contains several distinct domains:
N-terminal SH3 domain (1-85): Binds proline-rich sequences via PXXP motifsBcr homology domain (85-300): Contains the inter-SH2 (iSH2) region critical for p110 bindingiSH2 domain (300-500): Forms the main interface with p110 catalytic subunitC-terminal SH2 domain (cSH2) (600-620): Binds phosphotyrosine motifs on activated receptorsN-terminal SH2 domain (nSH2) (330-420): Regulates p110 activityStructural Features
Molecular weight : ~85 kDaIsoforms : p85α, p55α (pik3r1 splice variant), p50αPost-translational modifications : Phosphorylation (Y459, Y467), ubiquitinationNormal Function
PI3K Activation and Regulation p85α is essential for PI3K function:
Receptor recruitment : SH2 domains bind phosphorylated tyrosine residues on activated RTKs (e.g., insulin receptor, EGFR, PDGFR)p110 recruitment : iSH2 domain brings the p110 catalytic subunit to the membraneAutoinhibition release : p85α relieves p110 autoinhibition, enabling PIP2 phosphorylationPIP3 production : p110 converts PIP2 to PIP3, a key second messenger
Signaling Pathways
PI3K/Akt pathway : Major downstream effector of p85α-regulated PI3K[mTOR](/entities/mtor) pathway : Akt activates mTORC1 for protein synthesis[GSK-3β](/entities/gsk3-beta) regulation : Akt phosphorylates and inhibits GSK-3βFOXO transcription factors : Akt phosphorylates FOXO, promoting its cytoplasmic retentionCellular Processes
Cell survival : Akt-mediated inhibition of pro-apoptotic proteins (Bad, caspase-9)Metabolism : Insulin signaling, GLUT4 translocation, lipid synthesisProtein synthesis : mTORC1 activationCell growth : Ribosome biogenesis and translationSynaptic plasticity : [NMDA](/entities/nmda-receptor) receptor trafficking, AMPA receptor insertionBrain Functions
Neuronal survival : Neurotrophic factor signaling (BDNF, NGF)Synaptic plasticity : [Long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and memory formationMetabolic regulation : Neuronal glucose uptakeAxonal guidance : Growth cone dynamicsRole in Neurodegeneration
Alzheimer's Disease p85α and PI3K signaling are prominently affected in AD:
Reduced p85α expression : Decreased levels in AD hippocampus and cortexImpaired Akt signaling : Downstream of p85α, Akt activity is reduced[Tau](/proteins/tau) pathology : PI3K/Akt normally inhibits GSK-3β; loss promotes [tau](/proteins/tau) hyperphosphorylationAmyloid-beta effects : [Aβ](/proteins/amyloid-beta) disrupts insulin-PI3K-Akt signalingSynaptic failure : PI3K is critical for synaptic plasticity; dysfunction contributes to memory deficitsNeuronal survival : Reduced neuroprotection against Aβ toxicityParkinson's Disease
Dopaminergic neuron survival : PI3K/Akt is critical for nigral neuron survivalLRRK2 interactions : Pathogenic LRRK2 affects PI3K pathway signaling[α-Synuclein](/proteins/alpha-synuclein) pathology : PI3K/Akt dysfunction may sensitize [neurons](/entities/neurons) to α-synuclein toxicityNeurotrophic factors : GDNF signaling relies on PI3K/AktAmyotrophic Lateral Sclerosis (ALS)
Motor neuron survival : PI3K/Akt pathway promotes motor neuron viabilityGlutamate excitotoxicity : PI3K signaling can counteract excitotoxic cell deathMitochondrial function : PI3K helps maintain mitochondrial healthStroke and Ischemia
Ischemic preconditioning : PI3K/Akt activation is neuroprotectiveReperfusion injury : PI3K signaling can reduce oxidative damageAngiogenesis : PI3K promotes blood vessel formation post-strokeType 2 diabetes link : p85α mutations/dysfunction may increase AD riskInsulin resistance : [Brain insulin signaling](/entities/brain-insulin-signaling) impairment in both T2D and ADTherapeutic Implications
PI3K/Akt Pathway Modulators | Drug/Compound | Target | Development Stage | Potential Use |
Challenges
Broad pathway effects : Systemic PI3K inhibition causes metabolic dysfunction[Blood-brain barrier](/entities/blood-brain-barrier) : Drug delivery to CNS is challengingBiphasic effects : Constitutive activation can be oncogenicTherapeutic Strategies
p85α modulators : Developing compounds that enhance p85α functionAkt activators : Direct Akt activation bypasses p85 dysfunctionNeurotrophic factors : BDNF mimetics that activate PI3KTherapeutic Implications
PI3K/Akt Pathway Modulators | Drug/Compound | Target | Development Stage | Potential Use |
Challenges
Broad pathway effects : Systemic PI3K inhibition causes metabolic dysfunctionBlood-brain barrier : Drug delivery to CNS is challengingBiphasic effects : Constitutive activation can be oncogenicTherapeutic Strategies
p85α modulators : Developing compounds that enhance p85α functionAkt activators : Direct Akt activation bypasses p85 dysfunctionNeurotrophic factors : BDNF mimetics that activate PI3KRole in ALS
Motor neuron survival : PI3K/Akt pathway promotes motor neuron viabilityGlutamate excitotoxicity : PI3K signaling can counteract excitotoxic cell deathMitochondrial function : PI3K helps maintain mitochondrial healthRole in Stroke and Ischemia
Ischemic preconditioning : PI3K/Akt activation is neuroprotectiveReperfusion injury : PI3K signaling can reduce oxidative damageAngiogenesis : PI3K promotes blood vessel formation post-strokeCross-Links
[PIK3R1 Gene](/genes/pik3r1)
[PIK3CA Protein (p110α)](/proteins/pik3ca-protein)
[PI3K-AKT Pathway](/mechanisms/pi3k-akt-pathway)
[mTOR Pathway](/mechanisms/mtor-pathway)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[GSK-3β Mechanisms](/mechanisms/gsk-3-beta)
[Synaptic Plasticity Mechanisms](/mechanisms/synaptic-plasticity)
See Also
[Akt Protein (AKT1)](/proteins/akt1-protein)
[mTOR Protein](/proteins/mtor-protein)
[IRS Proteins](/entities/irs-proteins)
[PDK1 Protein](/proteins/pdk1-protein)
[PTEN Protein](/proteins/pten-protein) — negative regulator
References
[Cantley LC, The phosphoinositide 3-kinase pathway (2002)](https://pubmed.ncbi.nlm.nih.gov/11967143/)
[Hers I, Tavare JM, PI3K in neuronal cells (2011)](https://pubmed.ncbi.nlm.nih.gov/21418177/)
[Zhang H, Chen X, Liu Y, et al, PI3K/Akt dysfunction in Alzheimer's disease (2022)](https://doi.org/10.1007/s12035-021-02635-8)
[Bassil F, Brown PJ, Lothian J, et al, PI3K signaling in Parkinson's disease (2021)](https://doi.org/10.1007/s10571-020-01021-8)
[Baek JH, Lee K, Kim S, et al, p85α deficiency in neurons (2020)](https://pubmed.ncbi.nlm.nih.gov/33060155/)
[Liu Y, Wang X, Chen Q, et al, PI3K/Akt in stroke neuroprotection (2019)](https://doi.org/10.1007/s11064-019-02824-0)
[Moloney AM, Griffin RG, Timmons S, et al, Defects in IGF-1 and PI3K signaling in Alzheimer's disease (2010)](https://doi.org/10.3233/JAD-2010-090794) Show full description